U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
Contact Us FAQs Site Map About MedelinePlus
español

Reuters Health Information Logo

Low testosterone seen in men with type 2 diabetics

Printer-friendly version Printer-friendly version

Reuters Health

Tuesday, September 9, 2008

NEW YORK (Reuters Health) - Many young men with type 2 diabetes have abnormally low levels of testosterone, new research shows.

Their lack of the hormone may have "profound" implications for their sexual and reproductive health, Dr. Paresh Dandona of the State University of New York at Buffalo and his colleagues warn. "Whatever else is happening with diabetes and heart disease ... gross sexual dysfunction and infertility could be part of the story," Dandona told Reuters Health in an interview.

In 2004, Dandona and his colleagues reported low testosterone levels in middle-aged men with type 2 diabetes, as well as "inappropriately low" levels of luteinizing hormone and follicle-stimulating hormone, which are essential to fertility.

In the current study, the researchers tested hormone levels in 38 men with type 1 diabetes and 24 with type 2 diabetes, all of whom were between 18 and 35 years old. While testosterone, luteinizing hormone, and follicle-stimulating hormone levels in the type 1 diabetics were "perfect," Dandona told Reuters Health, with just 8 percent of them having subnormal testosterone levels.

One third of the type 2 diabetics had testosterone levels that were below normal and 58 percent had testosterone levels below normal for their age. Men with low testosterone levels also had low luteinizing hormone and follicle-stimulating hormone levels, indicating that they met diagnostic criteria for hypogonadotrophic hypogonadism, a condition in which the testes are unable to function properly due to problems with the hypothalamus or the pituitary gland.

According to Dandona, obesity, as well as insulin resistance and inflammation, likely work together to impair the hypothalamus' ability to trigger the hormonal cascade responsible for producing the necessary amounts of testosterone, luteinizing hormone, and follicle-stimulating hormone.

Treating hypogonadotrophic hypogonadism requires not only giving men testosterone to boost sex drive, but also injections of luteinizing hormone and follicle-stimulating hormone to restore fertility, the researcher said. It's not clear, he added, whether losing weight would restore hormonal balance in type 2 diabetic men with hypogonadotrophic hypogonadism. Dandona hypothesizes that "by the time you develop diabetes and you've got this problem, the reversibility element is largely gone."

Dandona and his colleagues have also found that "in some of these people semen analysis reveals hardly any spermatozoa," although they have not yet published this research. They are now planning additional research to determine if type 2 diabetes-related hypogonadotrophic hypogonadism in men is reversible with weight loss, as well as to understand how hypogonadotrophic hypogonadism affects sexual health and fertility in these men.

SOURCE: Diabetes Care, online July 23, 2008.


Reuters Health

Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Related News:
More News on this Date

Related MedlinePlus Pages: